Physician

Christopher Jared Sciamanna, DO

According to 2025 Medicare claims, Christopher Sciamanna, DO (NPI: 1760778880) practices advanced heart failure and transplant cardiology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ADVOCATE HEALTH AND HOSPITALS CORPORATION (NPI: 1700824455; TIN: 362169147) and primary practice location at 60453-2600. Sciamanna is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Sciamanna's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 178 traditional Medicare patients, billed 756 HCPCS/CPT codes, and received $68,403 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 395 prescription claims across 69 beneficiaries totaling $1,553,373 in drug costs, led by Uptravi (Selexipag). DME data shows 123 claims. Open Payments data shows 2 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $5,882 and ending at $68,403. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $208 to $1,553,373. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	49	85	$5,882
2018	114	460	$39,120
2019	237	1,488	$109,847
2020	166	911	$61,133
2021	146	678	$45,683
2022	185	698	$48,227
2023	200	724	$54,125
2024	178	756	$68,403

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	16	$208
2018	21	51	$1,798
2019	26	74	$7,299
2020	29	84	$12,352
2021	40	146	$420,887
2022	50	260	$819,064
2023	74	389	$745,872
2024	69	395	$1,553,373

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	24	$1,497
2022	N/R	195	$11,307
2023	N/R	277	$24,862
2024	N/R	123	$10,927

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	64	190	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	41	66	$75
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	41	106	$63
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	54	59	$50
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	45	72	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Uptravi	Selexipag	18	526	$494,183
Adempas	Riociguat	25	711	$336,915
Opsumit	Macitentan	14	420	$176,645
Entresto	Sacubitril/Valsartan	32	1,742	$35,836
Jardiance	Empagliflozin	22	1,020	$19,469

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	42	$6,547
J2260	Injection, milrinone lactate, 5 mg	N	N/R	38	$3,555
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	43	$825

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$25	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Jared Sciamanna, DO?

Tedicare shows public-source Medicare data for Christopher Jared Sciamanna, DO (NPI 1760778880), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Jared Sciamanna, DO have ACO affiliation data?

Christopher Jared Sciamanna, DO is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Christopher Jared Sciamanna, DO?

Christopher Jared Sciamanna, DO is linked to ADVOCATE HEALTH AND HOSPITALS CORPORATION (billing NPI 1700824455) in the available physician profile data.

Does Christopher Jared Sciamanna, DO have Open Payments data?

Christopher Jared Sciamanna, DO has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.